M&A Deal Summary |
|
|---|---|
| Date | 2020-10-26 |
| Target | Fertiláqua |
| Sector | Chemicals |
| Buyer(s) | ICL Group |
| Sellers(s) |
Quilvest Capital Partners
Aqua Capital |
| Deal Type | Add-on Acquisition |
| Deal Value | 120M USD |
SEARCH BY
Try For Free 7-Day Free Trial
ICL Group is a manufacturer of products based on specialty minerals that fulfill humanity's essential needs primarily in three markets: agriculture, food and engineered materials. ICL Group was founded in 1968 and is based in Tel Aviv, Israel.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 6 |
| Sector (Chemicals) | 2 of 4 |
| Type (Add-on Acquisition) | 3 of 4 |
| Country (Brazil) | 2 of 4 |
| Year (2020) | 2 of 2 |
| Size (of disclosed) | 2 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-02-19 |
Growers Holdings
Durham, North Carolina, United States Growers Holdings, Inc. is a provider in the field of process and data-driven farming. Growers' agronomic services platform enhances decision-making capabilities for farmers, agronomists, and other agro-professionals by creating easily adaptable and executable data-driven recommendations. Growers Holdings was established in 2011 and is based in Durham, North Carolina. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-03-24 |
Compass Minerals America do Sul S.A.
Mauá, Brazil Compass Minerals America do Sul S.A. is a specialty plant nutrition business in Brazil that offers a broad range of solutions for plant nutrition and stimulation, soil treatment, seed treatment, and plant health, covering all key Brazilian crops. Its product portfolio includes enhanced efficiency fertilizers and controlled-release fertilizers, soil and foliar macronutrients, secondary nutrients, biostimulants, and adjuvants. The business has an existing presence in 25 out of 26 Brazilian states and serves more than 32,000 farms directly and indirectly, with direct-to-farm sales accounting for approximately 50% of total sales. |
Buy | R$2.2B |
| Category | Private Equity Firm |
|---|---|
| Founded | 1972 |
| PE ASSETS | 6.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Quilvest Capital Partners is the private equity investment arm of asset management firm Quilvest. Quilvest Capital Partners invests in private equity and debt funds as well as makes direct investments. The direct investment group looks for opportunities in the US, Europe, and 'opportunistically' in Asia with a preference for buyout, growth capital, and venture transactions. Quilvest Capital Partners will consider both minority and majority positions. Quilvest Capital Partners was established in 1972 and is based Paris.
| DEAL STATS | # |
|---|---|
| Overall | 62 of 68 |
| Sector (Chemicals) | 1 of 1 |
| Type (Add-on Acquisition) | 24 of 27 |
| Country (Brazil) | 1 of 1 |
| Year (2020) | 3 of 4 |
| Size (of disclosed) | 19 of 20 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-06-15 |
Royalty Pharma
New York, New York, United States Royalty Pharma is a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals, and not-for-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly - directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma’s current portfolio includes royalties on more than 45 commercial products, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, and Vertex’s Kalydeco, Symdeko and Trikafta, and three development-stage product candidates. Royalty Pharma was formed in 1996 and is based in New York, New York. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-12-17 |
Wholesome Sweeteners
Sugar Land, Texas, United States Wholesome Sweeteners is a provider of organic and Fair Trade certified sweeteners both as ingredients to organic food and beverage brands and as branded products in the retail channel. |
Sell | $180M |
Aqua Capital is a private equity firm focused on growth investments in mid-market companies throughout the Brazilian and South American agribusiness value chain. Aqua looks to identify 'best-in-class' companies with significant growth opportunities and $15 to $250 million in revenue. Aqua Capital was formed in 2009 and is based in Sao Paulo.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 5 |
| Sector (Chemicals) | 1 of 1 |
| Type (Add-on Acquisition) | 1 of 4 |
| Country (Brazil) | 1 of 5 |
| Year (2020) | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-08-11 |
Puravida
São Paulo, Brazil Puravida offers health, beauty, and transformation through organic foods, concentrated nutrients, and products that bring well-being and happiness to people. Puravida to offer in Brazil an unprecedented level of criteria with raw materials, small stocks to always guarantee freshness, natural flavors that do not require artifices or harmful ingredients. Puravida is based in São Paulo, Brazil. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-07-19 |
AgroGalaxy
São Paulo, Brazil AgroGalaxy operates in the agricultural business in Brazil. It is involved in the sale of agricultural inputs and products, such as livestock, seeds, feed, machinery, and agricultural implements. AgroGalaxy was founded in 2016 and is based in São Paulo, Brazil. |
Sell | - |
